Philips has inked an eight-year strategic partnership worth up to $115 million with NYU Langone Health, the two announced Thursday.
As part of the deal, the top-ranked academic medical center will adopt Philips’ artificial intelligence-powered diagnostic imaging technologies, including handheld ultrasound. NYU also will add solutions in digital pathology and clinical informatics, allowing its radiologists and other providers to share imaging studies and other patient data to fuel real-time collaboration.
“Further harnessing big data is the next step in our commitment to ensuring that NYU Langone remains at the forefront of innovation and precision medicine that our patients have to come to expect,” Nader Mherabi, chief digital and information officer at NYU Langone, said in a Nov. 16 announcement from Philips.
In addition, the health system plans to implement the Philips Patient Information Center and Capsule Medical Device Information Platform. Leaders said the latter brings together disparate data from medical devices and other systems in a unified viewer to provide seamless integration across NYU’s network.
They also plan to deepen their existing partnership by establishing new research programs focused on ultrasound, MRI and digital pathology.
“NYU Langone has always been a trailblazer when it comes to technology adoption and providing world-class patient care,” Julia Strandberg, chief business leader of Connected Care for Philips, said in the announcement.
Marty Stempniak has covered healthcare since 2012, with his byline appearing in the American Hospital Association's member magazine, Modern Healthcare and McKnight's. Prior to that, he wrote about village government and local business for his hometown newspaper in Oak Park, Illinois. He won a Peter Lisagor and Gold EXCEL awards in 2017 for his coverage of the opioid epidemic.